Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,895.00
+80.00 (2.10%)
At close: Jan 26, 2026

KOSDAQ:142280 Revenue

Green Cross Medical Science had revenue of 26.45B KRW in the quarter ending September 30, 2025, a decrease of -1.77%. This brings the company's revenue in the last twelve months to 111.12B, up 11.43% year-over-year. In the year 2024, Green Cross Medical Science had annual revenue of 103.85B with 10.47% growth.

Revenue (ttm)
111.12B
Revenue Growth
+11.43%
P/S Ratio
0.77
Revenue / Employee
910.80M
Employees
122
Market Cap
85.88B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024103.85B9.84B10.47%
Dec 31, 202394.01B-19.10B-16.88%
Dec 31, 2022113.11B11.43B11.25%
Dec 31, 2021101.67B-11.70B-10.32%
Dec 31, 2020113.38B31.88B39.13%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Seoulin Bioscience76.74B
Dx & Vx29.47B
Cytogen25.09B
HLB Panagene14.29B
Protia13.52B
3billion9.78B
GENINUS8.81B
Median Diagnostics7.86B
Revenue Rankings